InsidersTradesSigma
Track the Mankind Pharma Limited stock price and the full management transaction log of the company, a publicly traded company based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Mankind Pharma Limited has published 3 insider filings. Market capitalisation: €1,019.9bn. The latest transaction was filed on 9 February 2024 (Sale). Among the most active insiders: Arjun Juneja. All data is accessible without an account.
Analysts rate Mankind Pharma Limited Buy (bullish), based on 19 analysts. Average price target: ₹2,675.37.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Mankind Pharma Limited是一家专注于医疗保健和制药领域的印度公司。它专门从事仿制药和医药产品的研究、开发和营销。